These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 32945513)
21. Antitumor activity and combined inhibitory effect of ceritinib with gemcitabine in pancreatic cancer. Jamshed MB; Munir F; Shahid N; Sadiq U; Muhammad SA; Ghanem NB; Zhong H; Li X; Zhang Q Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G109-G119. PubMed ID: 31736340 [TBL] [Abstract][Full Text] [Related]
22. Isodon eriocalyx and its bioactive component Eriocalyxin B enhance cytotoxic and apoptotic effects of gemcitabine in pancreatic cancer. Li L; Zhao SL; Yue GGL; Wong TP; Pu JX; Sun HD; Fung KP; Leung PC; Han QB; Lau CBS; Leung PS Phytomedicine; 2018 May; 44():56-64. PubMed ID: 29895493 [TBL] [Abstract][Full Text] [Related]
23. Gambogic acid sensitizes gemcitabine efficacy in pancreatic cancer by reducing the expression of ribonucleotide reductase subunit-M2 (RRM2). Xia G; Wang H; Song Z; Meng Q; Huang X; Huang X J Exp Clin Cancer Res; 2017 Aug; 36(1):107. PubMed ID: 28797284 [TBL] [Abstract][Full Text] [Related]
24. Enhancement of the effects of gemcitabine against pancreatic cancer by oridonin via the mitochondrial caspase-dependent signaling pathway. Liu DL; Bu HQ; Jin HM; Zhao JF; Li Y; Huang H Mol Med Rep; 2014 Dec; 10(6):3027-34. PubMed ID: 25242370 [TBL] [Abstract][Full Text] [Related]
25. Co-Delivery Using pH-Sensitive Liposomes to Pancreatic Cancer Cells: the Effects of Curcumin on Cellular Concentration and Pharmacokinetics of Gemcitabine. Xu H; Li Y; Paxton JW; Wu Z Pharm Res; 2021 Jul; 38(7):1209-1219. PubMed ID: 34189639 [TBL] [Abstract][Full Text] [Related]
26. Induction of pancreatic cancer cell apoptosis, invasion, migration, and enhancement of chemotherapy sensitivity of gemcitabine, 5-FU, and oxaliplatin by hnRNP A2/B1 siRNA. Gu WJ; Liu HL Anticancer Drugs; 2013 Jul; 24(6):566-76. PubMed ID: 23525071 [TBL] [Abstract][Full Text] [Related]
27. Gemcitabine and XCT790, an ERRα inverse agonist, display a synergistic anticancer effect in pancreatic cancer. Liu SL; Liang HB; Yang ZY; Cai C; Wu ZY; Wu XS; Dong P; Li ML; Zheng L; Gong W Int J Med Sci; 2022; 19(2):286-298. PubMed ID: 35165514 [TBL] [Abstract][Full Text] [Related]
28. Combinatorial Treatment of Tinzaparin and Chemotherapy Can Induce a Significant Antitumor Effect in Pancreatic Cancer. Sarantis P; Bokas A; Papadimitropoulou A; Koustas E; Theocharis S; Papakotoulas P; Schizas D; Papalampros A; Felekouras E; Papavassiliou AG; Karamouzis MV Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34208987 [TBL] [Abstract][Full Text] [Related]
29. Curcumin and paclitaxel induce cell death in breast cancer cell lines. Calaf GM; Ponce-Cusi R; Carrión F Oncol Rep; 2018 Oct; 40(4):2381-2388. PubMed ID: 30066930 [TBL] [Abstract][Full Text] [Related]
30. S-Adenosylmethionine synergistically enhances the antitumor effect of gemcitabine against pancreatic cancer through JAK2/STAT3 pathway. Liu Y; Bi T; Liu L; Gao Q; Shen G; Qin L Naunyn Schmiedebergs Arch Pharmacol; 2019 May; 392(5):615-622. PubMed ID: 30683944 [TBL] [Abstract][Full Text] [Related]
31. Antiprotease strategy in pancreatic cancer treatment: emergence from a preclinical study. Brandi G; Tavolari S; Guarnieri T; Di Marco M; Paterini P; Macchini M; Di Girolamo S; Papi A; De Rosa F; Biasco G Pancreas; 2014 Jan; 43(1):53-63. PubMed ID: 24201777 [TBL] [Abstract][Full Text] [Related]
32. Hyperthermia inhibits the motility of gemcitabine-resistant pancreatic cancer PANC-1 cells through the inhibition of epithelial-mesenchymal transition. Jin H; Zhao Y; Zhang S; Yang J; Zhang X; Ma S Mol Med Rep; 2018 May; 17(5):7274-7280. PubMed ID: 29568909 [TBL] [Abstract][Full Text] [Related]
33. Selective Nuclear Export Inhibitor KPT-330 Enhances the Antitumor Activity of Gemcitabine in Human Pancreatic Cancer. Kazim S; Malafa MP; Coppola D; Husain K; Zibadi S; Kashyap T; Crochiere M; Landesman Y; Rashal T; Sullivan DM; Mahipal A Mol Cancer Ther; 2015 Jul; 14(7):1570-81. PubMed ID: 25934708 [TBL] [Abstract][Full Text] [Related]
34. A humanized anti-IGF-1R monoclonal antibody (R1507) and/or metformin enhance gemcitabine-induced apoptosis in pancreatic cancer cells. Kawanami T; Takiguchi S; Ikeda N; Funakoshi A Oncol Rep; 2012 Mar; 27(3):867-72. PubMed ID: 22200743 [TBL] [Abstract][Full Text] [Related]
35. Monogalactosyl diacylglycerol, a replicative DNA polymerase inhibitor, from spinach enhances the anti-cell proliferation effect of gemcitabine in human pancreatic cancer cells. Akasaka H; Sasaki R; Yoshida K; Takayama I; Yamaguchi T; Yoshida H; Mizushina Y Biochim Biophys Acta; 2013 Mar; 1830(3):2517-25. PubMed ID: 23174220 [TBL] [Abstract][Full Text] [Related]
36. Curcumin sensitizes human lung cancer cells to apoptosis and metastasis synergistically combined with carboplatin. Kang JH; Kang HS; Kim IK; Lee HY; Ha JH; Yeo CD; Kang HH; Moon HS; Lee SH Exp Biol Med (Maywood); 2015 Nov; 240(11):1416-25. PubMed ID: 25716014 [TBL] [Abstract][Full Text] [Related]
37. Curcumin potentiates the antitumor effects of gemcitabine in an orthotopic model of human bladder cancer through suppression of proliferative and angiogenic biomarkers. Tharakan ST; Inamoto T; Sung B; Aggarwal BB; Kamat AM Biochem Pharmacol; 2010 Jan; 79(2):218-28. PubMed ID: 19682434 [TBL] [Abstract][Full Text] [Related]
38. In vitro Study of the Antagonistic Effect of Low-dose Liquiritigenin on Gemcitabine-induced Capillary Leak Syndrome in Pancreatic Adenocarcinoma via Inhibiting ROS- Mediated Signalling Pathways. Wu W; Xia Q; Luo RJ; Lin ZQ; Xue P Asian Pac J Cancer Prev; 2015; 16(10):4369-76. PubMed ID: 26028101 [TBL] [Abstract][Full Text] [Related]
39. Synergistic antitumor activity of ZD6474, an inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling, with gemcitabine and ionizing radiation against pancreatic cancer. Bianco C; Giovannetti E; Ciardiello F; Mey V; Nannizzi S; Tortora G; Troiani T; Pasqualetti F; Eckhardt G; de Liguoro M; Ricciardi S; Del Tacca M; Raben D; Cionini L; Danesi R Clin Cancer Res; 2006 Dec; 12(23):7099-107. PubMed ID: 17145834 [TBL] [Abstract][Full Text] [Related]
40. TIMP1 down-regulation enhances gemcitabine sensitivity and reverses chemoresistance in pancreatic cancer. Tan Y; Li X; Tian Z; Chen S; Zou J; Lian G; Chen S; Huang K; Chen Y Biochem Pharmacol; 2021 Jul; 189():114085. PubMed ID: 32522594 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]